Literature DB >> 17406953

Effects of anticholinergics and beta-agonists in COPD.

John Hansen-Flaschen.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17406953      PMCID： PMC2219882          DOI： 10.1007/s11606-006-0096-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  3 in total

1.  Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.

Authors:  Shelley R Salpeter; Nicholas S Buckley; Edwin E Salpeter
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

2.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  Peter Calverley; Romain Pauwels; Jørgen Vestbo; Paul Jones; Neil Pride; Amund Gulsvik; Julie Anderson; Claire Maden
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

3.  Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease.

Authors:  P M Calverley; W Boonsawat; Z Cseke; N Zhong; S Peterson; H Olsson
Journal:  Eur Respir J       Date:  2003-12       Impact factor: 16.671
  3 in total
  1 in total

1.  Knowledge and attitudes of family physicians coming to COPD continuing medical education.

Authors:  Barbara P Yawn; Peter C Wollan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.